Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Risk Profile, Efficacy and Safety of Rituximab in Patients with Relapsed or Refractory Idiopathic Thrombocytopenic Purpura in a Minority Cohort with Long Term Follow up

Shylendra B Sreenivasappa, MD, R. Catchatourian, MD, Barbara Yim, Pharm.D

Blood (2008) 112 (11): 4546.

https://doi.org/10.1182/blood.V112.11.4546.4546

Published: 2008

Journal Articles

Clinical Presentation, Risk Profiles and Outcomes of Chemotherapy without Bone Marrow Transplant in a Cohort of Minority Patients with Acute Lymphoblastic Leukemia from a Public Health Hospital

Bety Ciobanu, MD, Shylendra B Sreenivasappa, MD, Tracy Smiley, RN, Barbara Yim, Pharm.D, Paula Kovarik, MD, Mousami Shah, MD, Rafid Kouz, MD, Samuel Ofori, MD, Margaret Clare Telfer, MD, Rosalind Catchatourian, MD

Blood (2008) 112 (11): 3958.

https://doi.org/10.1182/blood.V112.11.3958.3958

Published: 2008

Journal Articles

Fludarabine Combination Therapy Response, Progression and Toxicity Profile in a Minority Predominant Population with Chronic Lymphocytic Leukemia from a Public Health Hospital

Bety Ciobanu, MD, Shylendra B Sreenivasappa, MD, Barbara Yim, Pharm.D, Tracy Smiley, RN, Victoria Angelova, MD, Paula Kovarik, MD, Samuel Ofori, MD, Mousami Shah, MD, Rafid Kouz, MD, Margaret Clare Telfer, MD, Rosalind Catchatourian, MD

Blood (2008) 112 (11): 4213.

https://doi.org/10.1182/blood.V112.11.4213.4213

Published: 2008

Journal Articles

Presentation Characteristics, Risk Profiles and Response to Thalidomide in a Public Health System, Minority Patient Population with Multiple Myeloma

Shylendra B Sreenivasappa, MD, Mousami Shah, MD, Rosalind Catchatourian, MD, Luciano Fochesatto, MD, Barbara Yim, Pharm.D

Blood (2008) 112 (11): 5189.

https://doi.org/10.1182/blood.V112.11.5189.5189

Published: 2008

Journal Articles

Presentation Characteristics, Risk Profiles and Long-Term Outcomes in a Public Health System, Minority Patient Population with Chronic Lymphocytic Leukemia.

Sunita Nathan, MD, Olusola Ogundipe, MD, Perry Menini, DO, Anshul Bamrolia, MD, Decebal S. Griza, MD, Tracy Smiley, RN, Bhuvaneswari Subramanian, MD, Ahmad Jajeh, MD, Margaret Clare Telfer, MD, R. Catchatourian, MD

Blood (2006) 108 (11): 4956.

https://doi.org/10.1182/blood.V108.11.4956.4956

Published: 2006

Journal Articles

The Risk of Venous Thromboembolism Following Hospitalization in Medical Patients without Cancer.

Louis D. Fiore, MD, MPH, Amy Fallon, MD, Melissa Young, MPH, Elizabeth V. Lawler, DSc, MPH, Mary T. Brophy, MD, MPH

Blood (2006) 108 (11): 714.

https://doi.org/10.1182/blood.V108.11.714.714

Published: 2006

Journal Articles

Outcome after Relapse among Children with Standard Risk (SR) ALL Treated on CCG-1952.

Suman Malempati, MD, Paul S. Gaynon, MD, Harland Sather, PhD, Mei K. La, MS, Linda C. Stork, MD

Blood (2004) 104 (11): 520.

https://doi.org/10.1182/blood.V104.11.520.520

Published: 2004

NARROW

Risk Profile, Efficacy and Safety of Rituximab in Patients with Relapsed or Refractory Idiopathic Thrombocytopenic Purpura in a Minority Cohort with Long Term Follow up

Clinical Presentation, Risk Profiles and Outcomes of Chemotherapy without Bone Marrow Transplant in a Cohort of Minority Patients with Acute Lymphoblastic Leukemia from a Public Health Hospital

Fludarabine Combination Therapy Response, Progression and Toxicity Profile in a Minority Predominant Population with Chronic Lymphocytic Leukemia from a Public Health Hospital

Presentation Characteristics, Risk Profiles and Response to Thalidomide in a Public Health System, Minority Patient Population with Multiple Myeloma

Presentation Characteristics, Risk Profiles and Long-Term Outcomes in a Public Health System, Minority Patient Population with Chronic Lymphocytic Leukemia.

The Risk of Venous Thromboembolism Following Hospitalization in Medical Patients without Cancer.

Outcome after Relapse among Children with Standard Risk (SR) ALL Treated on CCG-1952.

Email alerts

ASH Publications

American Society of Hematology

Risk Profile, Efficacy and Safety of Rituximab in Patients with Relapsed or Refractory Idiopathic Thrombocytopenic Purpura in a Minority Cohort with Long Term Follow up

Clinical Presentation, Risk Profiles and Outcomes of Chemotherapy without Bone Marrow Transplant in a Cohort of Minority Patients with Acute Lymphoblastic Leukemia from a Public Health Hospital

Fludarabine Combination Therapy Response, Progression and Toxicity Profile in a Minority Predominant Population with Chronic Lymphocytic Leukemia from a Public Health Hospital

Presentation Characteristics, Risk Profiles and Response to Thalidomide in a Public Health System, Minority Patient Population with Multiple Myeloma

Presentation Characteristics, Risk Profiles and Long-Term Outcomes in a Public Health System, Minority Patient Population with Chronic Lymphocytic Leukemia.

The Risk of Venous Thromboembolism Following Hospitalization in Medical Patients without Cancer.

Outcome after Relapse among Children with Standard Risk (SR) ALL Treated on CCG-1952.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only